SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-007520
Filing Date
2021-02-09
Accepted
2021-02-08 19:03:04
Documents
3
Period of Report
2021-02-08

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea134898-6k_nlsphar.htm 6-K 12075
2 AMENDED AND RESTATED ARTICLES OF ASSOCIATION ea134898ex3-1_nlspharma.htm EX-3.1 286717
3 MARKED COPY OF AMENDED AND RESTATED ARTICLES OF ASSOCIATION ea134898ex3-2_nlspharma.htm EX-3.2 291230
  Complete submission text file 0001213900-21-007520.txt   590988
Mailing Address ALTER POSTPLATZ 2 STANS V8 CH-6370
Business Address ALTER POSTPLATZ 2 STANS V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 21603118
SIC: 2834 Pharmaceutical Preparations